| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $812.0M | +97.0% |
| R&D Expense | $101.6M | -10.8% |
| SG&A Expense | $225.0M | +32.8% |
| Operating Income | $45.1M | +117.5% |
| Interest Expense | $56.8M | +13.7% |
| Pre-tax Income | -$68.1M | +75.8% |
| Income Tax | $0 | — |
| Net Income | -$68.1M | +75.8% |
| EPS (Basic) | -$3.22 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $796.3M | +1145.2% |
| Short-term Investments | $2.3M | +4.3% |
| Accounts Receivable | $112.1M | +27.1% |
| Current Assets | $997.8M | +362.5% |
| Total Assets | $1.13B | +227.5% |
| Current Liabilities | $127.1M | -23.1% |
| Long-term Debt | $378.4M | +1.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $83.2M | +133.9% |
| Capital Expenditures | $16.3M | +92.6% |
| Investing Cash Flow | -$16.3M | -130.7% |
| Financing Cash Flow | $665.0M | +232.0% |
| Free Cash Flow | $66.9M | +126.4% |
| +69.8% |
| EPS (Diluted) | -$3.22 | +69.8% |
| Total Liabilities |
| $548.4M |
| -11.7% |
| Stockholders' Equity | $577.3M | +123.1% |